Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results Feb 26, 2026 07:00AM
Entrada Therapeutics to Present at Upcoming Investor Conferences Feb 4, 2026 07:00AM
TD Cowen on Biotechnology: '10+ Potential "Thome Run" Catalysts To Watch In 2026' Dec 19, 2025 09:06AM
Entrada Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results Feb 27, 2025 07:00AM
TD Cowen Reiterates Buy Rating on Entrada Therapeutics (TRDA) Aug 14, 2024 12:14PM


Jun 24, 2024 02:09PM TD Cowen Reiterates Buy Rating on Entrada Therapeutics (TRDA)
Feb 7, 2024 07:00AM Entrada Therapeutics to Present at Upcoming Investor Conferences
Mar 6, 2023 07:00AM Entrada Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
Mar 6, 2023 07:00AM Entrada Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
Feb 27, 2023 07:00AM Entrada Therapeutics to Participate in Cowen 43rd Annual Health Care Conference
Feb 27, 2023 07:00AM Entrada Therapeutics to Participate in Cowen 43rd Annual Health Care Conference
Feb 23, 2022 08:00AM Entrada Therapeutics to Participate in Cowen 42nd Annual Health Care Conference
Feb 23, 2022 08:00AM Entrada Therapeutics to Participate in Cowen 42nd Annual Health Care Conference
Nov 23, 2021 05:34AM UPDATE: Cowen Starts Entrada Therapeutics (TRDA) at Outperform
Nov 2, 2021 04:26PM Entrada Therapeutics Announces Closing of Initial Public Offering
Nov 2, 2021 04:26PM Entrada Therapeutics Announces Closing of Initial Public Offering
Oct 29, 2021 11:23AM Entrada Therapeutics (TRDA) IPO Opens 33% Higher
Oct 29, 2021 05:34AM Entrada Therapeutics, Inc. (TRDA) Prices Upsized 9.075M Share IPO at $20/sh
Oct 28, 2021 10:21PM Entrada Therapeutics Announces Pricing of Upsized Initial Public Offering
Oct 28, 2021 10:21PM Entrada Therapeutics Announces Pricing of Upsized Initial Public Offering
Oct 11, 2021 06:08AM Entrada Therapeutics (TRDA) Files For Up to $100M IPO